Postby GrouseMan » Thu Apr 09, 2015 6:25 pm
Well some additional information is scheduled to be presented at AACR April 18th to the 22nd at the meeting in Philadelphia. I think the CRC study is still ongoing.
See:
http://www.advfn.com/news_Biothera-to-P ... 06715.htmlSeems like they are still in Phase II and Phase III studies for different tumor types. Doesn't look like they are releasing any new data from these studies as yet especially for CRC. The AACR papers look like small animal studies on the mechanism of action, and synergies with other agents.
Regards,
GrouseMan
DW 53 dx Jun 2013
CT mets Liver Spleen lung. IVb CEA~110
Jul 2013 Sig Resct
8/13 FolFox,Avastin 12Tx mild sfx, Ongoing 5-FU Avastin every 3 wks.
CEA: good marker
7/7/14 CT Can't see the spleen Mets.
8/16/15 CEA Up, CT new abdominal mets. Iri, 5-FU, Avastin every 2 wks.
1/16 Iri, Erbitux and likely Avastin (Trial) CEA going >.
1/17 CEA up again dropped from Trial, Mets growth 4-6 mm in abdomen
5/2/17 Failed second trial, Hospitalized 15 days 5/11. Home Hospice 5/26, at peace 6/4/2017